Clinical Trials Browser

Interventional × larotrectinib × Tumor-Agnostic × Clear all

NCT04879121 2026-04-16

Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors

Phase 2 Recruiting

Neoplasm Metastasis

NCT02637687 2025-06-22

SCOUT

Phase 1/2 Active not recruiting

154 enrolled 2 FDA

Neoplasms